Company Filing History:
Years Active: 2008
Title: The Innovative Contributions of Friedrich W. Richter
Introduction
Friedrich W. Richter, based in Lake Bluff, IL, is a notable inventor whose contributions have significantly advanced pharmaceutical formulations. With a unique focus on peptide angiogenesis inhibitors, Richter's inventive work demonstrates a commitment to enhancing medical therapies.
Latest Patents
Richter holds a patent for a pharmaceutical formulation comprising a peptide angiogenesis inhibitor. This innovative patent, which discusses parenteral formulations of peptides, is designed for sustained release and outlines methods of preparation for these formulations. His work supports advancements in treatment methods for various health conditions.
Career Highlights
Richter is currently associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. His tenure at Abbott Laboratories has been marked by a dedication to research and development, contributing to the company's reputation for innovation in pharmaceuticals.
Collaborations
Throughout his career, Richter has collaborated with esteemed colleagues, including Fortuna Haviv and Bryan K. Erickson. These partnerships have fostered an environment of innovation, driving forward their shared goal of developing effective medical solutions.
Conclusion
Friedrich W. Richter continues to be a pivotal figure in the field of pharmaceutical innovation. His work not only exemplifies the importance of scientific research but also highlights his commitment to improving patient care through advanced medicinal formulations.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.